Community

David S. Johnson, Ph.D., MBA

,

Chief Executive Officer and Co-Founder, GigaGen
Dr. Johnson is an inventor, entrepreneur, and expert in single-cell immunology, with a track
record of bringing new medical technologies to market. Since founding GigaGen, Dr. Johnson raised approximately $52 million in partnerships with established pharmaceutical companies, including Grifols, Novartis, and Merck, and led the company through a merger agreement with
Grifols in early 2021 at a valuation of $142.9M. He also served as principal investigator for 16 grants totaling over $10 million from the National Science Foundation, National Cancer Institute and National Institute of Allergy and Infectious Diseases, including seven Phase 2 projects. Prior to GigaGen, Dr. Johnson was a founding member and chief operating officer of Natera, a reproductive molecular diagnostics firm.